[Pathogenetic treatment of non-alcoholic steatohepatitis: arguments, efficacy, safety].
Bueverov
A O
AO
Bogomolov
P O
PO
Maevskaia
M V
MV
D005081:Exercise Therapy / Q000379:methods*; D005227:Fatty Acids / Q000378:metabolism*; D005234:Fatty Liver / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
D005227:Fatty Acids; D007004:Hypoglycemic Agents; D007155:Immunologic Factors; D045162:Thiazolidinediones; D008687:Metformin